XML 93 R21.htm IDEA: XBRL DOCUMENT v2.4.1.9
Selected Quarterly Financial Data
12 Months Ended
Dec. 31, 2014
Selected Quarterly Financial Data [Abstract]  
Selected Quarterly Financial Data

(14)Selected Quarterly Financial Data (unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal Quarter Ended

 

 

March 31,

 

June 30,

 

September 30,

 

December 31,

 

March 31,

 

June 30,

 

September 30,

 

December 31,

 

 

2013

 

2013

 

2013

 

2013

 

2014

 

2014

 

2014

 

2014

 

 

(in thousands, except per share amounts)

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Healthcare

$

35,727 

$

33,871 

$

32,646 

$

32,896 

$

39,984 

$

37,592 

$

38,600 

$

39,813 

Commuter

 

14,707 

 

14,722 

 

14,949 

 

15,201 

 

16,043 

 

15,050 

 

15,078 

 

15,605 

COBRA

 

3,492 

 

3,673 

 

3,837 

 

4,045 

 

4,038 

 

3,701 

 

9,544 

 

14,713 

Other

 

2,189 

 

2,295 

 

2,139 

 

2,889 

 

2,555 

 

2,414 

 

4,776 

 

8,326 

Total revenues

 

56,115 

 

54,561 

 

53,571 

 

55,031 

 

62,620 

 

58,757 

 

67,998 

 

78,457 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues (excluding amortization of internal use software)

 

20,613 

 

19,932 

 

19,300 

 

22,073 

 

22,797 

 

21,157 

 

24,951 

 

31,321 

Sales and marketing, technology and development and general and administrative

 

23,541 

 

23,167 

 

23,832 

 

23,232 

 

24,498 

 

25,169 

 

30,771 

 

35,127 

Amortization and change in contingent consideration

 

4,462 

 

4,725 

 

554 

 

1,871 

 

4,420 

 

4,549 

 

5,688 

 

6,335 

Total operating expenses

 

48,616 

 

47,824 

 

43,686 

 

47,176 

 

51,715 

 

50,875 

 

61,410 

 

72,783 

Income from operations

 

7,499 

 

6,737 

 

9,885 

 

7,855 

 

10,905 

 

7,882 

 

6,588 

 

5,674 

Other, net

 

(352)

 

(349)

 

(316)

 

(57)

 

(243)

 

(242)

 

215 

 

(594)

Income before income taxes

 

7,147 

 

6,388 

 

9,569 

 

7,798 

 

10,662 

 

7,640 

 

6,803 

 

5,080 

Income tax provision

 

(2,511)

 

(2,396)

 

(1,818)

 

(2,478)

 

(4,218)

 

(3,053)

 

(2,690)

 

(1,982)

Net income

$

4,636 

$

3,992 

$

7,751 

$

5,320 

$

6,444 

$

4,587 

$

4,113 

$

3,098 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

$

0.14 

$

0.12 

$

0.23 

$

0.15 

$

0.19 

$

0.13 

$

0.12 

$

0.09 

Diluted

$

0.14 

$

0.11 

$

0.22 

$

0.15 

$

0.18 

$

0.13 

$

0.11 

$

0.08 

Shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

32,226 

 

33,473 

 

34,134 

 

34,638 

 

34,831 

 

35,117 

 

35,234 

 

35,393 

Diluted

 

33,841 

 

35,047 

 

35,785 

 

36,313 

 

36,303 

 

36,340 

 

36,152 

 

36,517 

 

 

In the third and fourth quarters of fiscal 2013, the Company made fair value adjustments to the contingent consideration liability related to the BCI acquisition as are disclosed within Note 1 to our consolidated financial statements under “Fair Value of Financial Instruments.”